See the published version of this preprint at Virology Journal.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research
Murat Altuntas
Clinic of Family Medicine, University of Health Sciences Bagcılar Research and Training Hospital, Istanbul, Turkey
Corresponding Author
ORCiD: https://orcid.org/0000-0003-0282-2721
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Aim: Covid-19 is one of the most important pandemics in the world history. Chronic diseases, which are risk factors that increase the case fatality rates, have been the leading cause of death all over the world. In this study, it was aimed to detect coexisting diseases in patients hospitalized with the diagnosis of Covid-19.
Material and Method: It was carried out with the data of 229 inpatients in an intensive care unit between 01.06.2020 - 30.06.2020. Among the inclusion criteria of the study; it is necessary to have a diagnosis confirmed by PCR test, to be hospitalized in the relevant intensive care unit on the date of the study and to have data accessible through the hospital automation system. According to literature; chronic diseases of the patients and their effects on the covid-19 process were evaluated. Statistical analyzes were performed using the Statistical Package for Social Sciences (SPSS) version 24.0 (IBM Corp .; Armonk, NY, USA).
Results: It was seen that the average age of the patients were 61.4±15.9 years old. While the average symptom duration was 8.2±5.3 days; total hospitalization period was 13.1±5.9 days. The length of stay of 75 patients who were sent to intensive care unit was determined as 10.1±7.1. The most common chronic disease among patients was hypertension with 47.2%. This was followed by diabetes mellitus (32.8%) and heart disease (27.5%), respectively. In the presented study, cough (59.4%), fever (58.5%) and shortness of breath (45.9%) were found to be the most common symptoms. Leukopenia, impairments in liver and muscle enzymes, abnormal C-reactive protein, ferritin and d-dimer levels were the important laboratory findings.
Conclusion: Particular attention should be paid to the elderly Covid-19 patients with chronic diseases, especially DM, HT and cancer.
Keywords
Chronic disease, Covid-19, diagnosis, patient
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at Virology Journal.
Version (no preprint)
Posted 26 Feb, 2021
Editorial decision: Minor revision
On 26 Feb, 2021
Reviewer #2 agreed
On 23 Feb, 2021
Reviewer #3 agreed
On 23 Feb, 2021
Reviewers invited
Invitations sent on 23 Feb, 2021
Reviewer #1 agreed
On 23 Feb, 2021
Review #1 received
Received 23 Feb, 2021
Review #2 received
Received 23 Feb, 2021
Review #3 received
Received 23 Feb, 2021
Editor assigned
On 22 Feb, 2021
Submission checks complete
On 22 Feb, 2021
Editor invited
On 22 Feb, 2021
This version was not preprinted
Version 1
Posted 30 Dec, 2020
No community comments so far
Review #2 received
Received 10 Jan, 2021
Editorial decision: Major revision
On 10 Jan, 2021
Review #3 received
Received 09 Jan, 2021
Review #4 received
Received 06 Jan, 2021
Review #1 received
Received 02 Jan, 2021
Reviewer #4 agreed
On 26 Dec, 2020
Reviewer #3 agreed
On 25 Dec, 2020
Reviewer #2 agreed
On 24 Dec, 2020
Reviewers invited
Invitations sent on 23 Dec, 2020
Reviewer #1 agreed
On 23 Dec, 2020
Editor assigned
On 21 Dec, 2020
Submission checks complete
On 21 Dec, 2020
Editor invited
On 21 Dec, 2020
First submitted
On 15 Dec, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Learn more about our company.
See the published version of this preprint at Virology Journal.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research
Murat Altuntas
Clinic of Family Medicine, University of Health Sciences Bagcılar Research and Training Hospital, Istanbul, Turkey
Corresponding Author
ORCiD: https://orcid.org/0000-0003-0282-2721
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at Virology Journal.
Version (no preprint)
Posted 26 Feb, 2021
Editorial decision: Minor revision
On 26 Feb, 2021
Reviewer #2 agreed
On 23 Feb, 2021
Reviewer #3 agreed
On 23 Feb, 2021
Reviewers invited
Invitations sent on 23 Feb, 2021
Reviewer #1 agreed
On 23 Feb, 2021
Review #1 received
Received 23 Feb, 2021
Review #2 received
Received 23 Feb, 2021
Review #3 received
Received 23 Feb, 2021
Editor assigned
On 22 Feb, 2021
Submission checks complete
On 22 Feb, 2021
Editor invited
On 22 Feb, 2021
This version was not preprinted
Version 1
Posted 30 Dec, 2020
No community comments so far
Review #2 received
Received 10 Jan, 2021
Editorial decision: Major revision
On 10 Jan, 2021
Review #3 received
Received 09 Jan, 2021
Review #4 received
Received 06 Jan, 2021
Review #1 received
Received 02 Jan, 2021
Reviewer #4 agreed
On 26 Dec, 2020
Reviewer #3 agreed
On 25 Dec, 2020
Reviewer #2 agreed
On 24 Dec, 2020
Reviewers invited
Invitations sent on 23 Dec, 2020
Reviewer #1 agreed
On 23 Dec, 2020
Editor assigned
On 21 Dec, 2020
Submission checks complete
On 21 Dec, 2020
Editor invited
On 21 Dec, 2020
First submitted
On 15 Dec, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at Virology Journal.
Aim: Covid-19 is one of the most important pandemics in the world history. Chronic diseases, which are risk factors that increase the case fatality rates, have been the leading cause of death all over the world. In this study, it was aimed to detect coexisting diseases in patients hospitalized with the diagnosis of Covid-19.
Material and Method: It was carried out with the data of 229 inpatients in an intensive care unit between 01.06.2020 - 30.06.2020. Among the inclusion criteria of the study; it is necessary to have a diagnosis confirmed by PCR test, to be hospitalized in the relevant intensive care unit on the date of the study and to have data accessible through the hospital automation system. According to literature; chronic diseases of the patients and their effects on the covid-19 process were evaluated. Statistical analyzes were performed using the Statistical Package for Social Sciences (SPSS) version 24.0 (IBM Corp .; Armonk, NY, USA).
Results: It was seen that the average age of the patients were 61.4±15.9 years old. While the average symptom duration was 8.2±5.3 days; total hospitalization period was 13.1±5.9 days. The length of stay of 75 patients who were sent to intensive care unit was determined as 10.1±7.1. The most common chronic disease among patients was hypertension with 47.2%. This was followed by diabetes mellitus (32.8%) and heart disease (27.5%), respectively. In the presented study, cough (59.4%), fever (58.5%) and shortness of breath (45.9%) were found to be the most common symptoms. Leukopenia, impairments in liver and muscle enzymes, abnormal C-reactive protein, ferritin and d-dimer levels were the important laboratory findings.
Conclusion: Particular attention should be paid to the elderly Covid-19 patients with chronic diseases, especially DM, HT and cancer.
Loading...